000 00989 a2200241 4500
005 20250517103352.0
264 0 _c20160701
008 201607s 0 0 eng d
022 _a1756-283X
024 7 _a10.1177/1756283X16644249
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKabeshova, Anastasiia
245 0 0 _aCost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.
_h[electronic resource]
260 _bTherapeutic advances in gastroenterology
_cJul 2016
300 _a473-82 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aBen Hariz, Soumaia
700 1 _aTsakeu, Elyonore
700 1 _aBenamouzig, Robert
700 1 _aLaunois, Robert
773 0 _tTherapeutic advances in gastroenterology
_gvol. 9
_gno. 4
_gp. 473-82
856 4 0 _uhttps://doi.org/10.1177/1756283X16644249
_zAvailable from publisher's website
999 _c26179272
_d26179272